PROCA1 and neoplasm: By comparison, injection of ProCA1 without the GRPR targeting moiety or use of the clinical contrast agent Gd-DTPA to the tumor bearing mice did not result in any significant MRI contrast enhancement in tumor regions under the same conditions (Fig. 4b).